

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb50488</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Exogenous Production of N-acetylmuramyl-L Alanine Amidase (LysM2) from  Siphoviridae Phage Affecting Anti-Gram-Negative Bacteria: Evaluation of Its Structure and Function</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Miri</surname><given-names>Morteza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Yazdianpour</surname><given-names>Sepideh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Abolmaali</surname><given-names>Shamsozoha</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Darvish Alipour Astaneh </surname><given-names>Shakiba</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <fpage>46</fpage>
      <lpage>53</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>7</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>10</month>
          <year>2021</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; To obtain endolysin with impact(s) on gram-negative bacteria as well as gram-positive bacteria, N-acetylmuramyl L-alanine-amidase&lt;em&gt; &lt;/em&gt;(MurNAc-LAA) from a &lt;em&gt;Bacillus subtilis&lt;/em&gt;-hosted Siphoviridae phage (SPP1 phage, Subtilis Phage Pavia 1) was exogenously expressed in &lt;em&gt;Escherichia coli (&lt;/em&gt;&lt;em&gt;E. coli).&lt;/em&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The sequences of &lt;em&gt;MurNAc-LAA&lt;/em&gt; genes encoding peptidoglycan hydrolases were obtained from the Virus-Host database. The sequence of&lt;em&gt; &lt;/em&gt;MurNAc-LAA&lt;em&gt; &lt;/em&gt;was optimized by GenScript software to generate&lt;em&gt; &lt;/em&gt;MurNAc-LAA-MMI (LysM2) for optimal expression in &lt;em&gt;E. coli&lt;/em&gt;. Furthermore, the structure and function of&lt;em&gt; &lt;/em&gt;LysM2 was evaluated &lt;em&gt;in silico.&lt;/em&gt; The optimized gene was synthesized, subcloned in the pET28a, and expressed in &lt;em&gt;E. coli&lt;/em&gt; BL21(DE3). The antibacterial effects of the protein on the peptidoglycan substrates were studied. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &lt;em&gt;LysM2&lt;/em&gt;, on 816 &lt;em&gt;bp&lt;/em&gt; gene encoding a 33 &lt;em&gt;kDa&lt;/em&gt; protein was confirmed as specific SPP1 phage enzyme. The enzyme is composed of 271 amino acids, with a half-life of 10 &lt;em&gt;hr&lt;/em&gt; in &lt;em&gt;E.&lt;/em&gt;&lt;/span&gt;&lt;em&gt; &lt;/em&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;coli&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. &lt;em&gt;In silico&lt;/em&gt; analyses showed 34.2% alpha-helix in the secondary structure, hydrophobic N-terminal, and lysine-rich C-terminal, and no antigenic properties in LysM2 protein. This optimized endolysin revealed impacts against &lt;em&gt;Proteus &lt;/em&gt;(sp) by turbidity, and an antibacterial activity against &lt;em&gt;Klebsiella pneumoniae&lt;/em&gt;, &lt;em&gt;Salmonella typhimurium&lt;/em&gt;, and &lt;em&gt;Proteus vulgaris&lt;/em&gt; in agar diffusion assays. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Taken together, our results confirmed that LysM2 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;is an inhibiting agent for gram-negative bacteria.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
